Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival (Q36608502)

15 August 2017

Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival (English)

1 reference

15 August 2017

1 reference

1 reference

Jd Wright

1

1 reference

15 August 2017

T Doan

2

1 reference

15 August 2017

R McBride

3

1 reference

15 August 2017

Js Jacobson

4

1 reference

15 August 2017

Dl Hershman

5

1 reference

15 August 2017

language of work or name

English

0 references

publication date

18 March 2008

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

98

1 reference

15 August 2017

7

1 reference

15 August 2017

1197-1203

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604298

15 August 2017

0 references

cites work

The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Utility of the SEER-Medicare data to identify chemotherapy use.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Assessing comorbidity using claims data: an overview

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Development of a comorbidity index using physician claims data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Racial differences in the treatment of early-stage lung cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Long-term follow-up of patients with advanced ovarian cancer treated in randomised clinical trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Predictors of comprehensive surgical treatment in patients with ovarian cancer.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Relationship between time interval from primary surgery to the start of taxane- plus platinum-based chemotherapy and clinical outcome of patients with advanced epithelial ovarian cancer: results of a multicenter retrospective Italian study.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Ovarian cancer surgery in Maryland: volume-based access to care.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer?

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

20 September 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604298

Variations in the Use of Chemotherapy for Elderly Patients With Advanced Ovarian Cancer: A Population-Based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604298

Influence of interval between primary surgery and chemotherapy on short-term survival of patients with advanced ovarian, tubal or peritoneal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604298

Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604298

Timing of chemotherapy and surgery in a murine osteosarcoma model

21 January 2018

1 reference

12 December 2020

Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study

1 reference

12 December 2020

How many more nails to seal the coffin of dose intensity?

1 reference

12 December 2020

Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. London Gynaecological Oncology Group

1 reference

12 December 2020

Racial disparities in treatment and survival among women with early-stage breast cancer

1 reference

12 December 2020

Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection

1 reference

12 December 2020

Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients

1 reference

12 December 2020

Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women

1 reference

12 December 2020

Ovarian cancer: patterns of surgical care across the United States

1 reference

12 December 2020

Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer

1 reference

12 December 2020

Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer?

1 reference

12 December 2020

Advanced epithelial ovarian cancer in the elderly: chemotherapy tolerance and outcome

1 reference

12 December 2020

Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens

1 reference

12 December 2020

The effect of centralization of primary surgery on survival in ovarian cancer patients

1 reference

12 December 2020

Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group

1 reference

12 December 2020

A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?

1 reference

12 December 2020

Age contrasts in clinical characteristics and pattern of care in patients with epithelial ovarian cancer

1 reference

12 December 2020

Outcomes in surgery for ovarian cancer

1 reference

12 December 2020

Does Timing of Adjuvant Chemotherapy for Early Breast Cancer Influence Survival?

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6604298

1 reference

15 August 2017

1 reference

15 August 2017

1 reference